BURLINGAME, Calif.--(BUSINESS WIRE)--Genesis Therapeutics, a company pioneering generative and predictive artificial intelligence (AI) technologies to develop breakthrough therapeutics for underserved ...
The company’s master lease matures on April 30, 2026, but Genesis last month indicated it would exercise a five-year extension option. Genesis holdings are still largely concentrated in the ...
The GV90 is expected to arrive in mid-2026 as the first vehicle built on Hyundai’s new eM platform. Genesis has yet to reveal when it will launch the luxury off-roader, but it’s expected to arrive as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback